CAPTRUST Financial Advisors
BCAB icon

CAPTRUST Financial Advisors’s BioAtla BCAB Stock Holding History

CAPTRUST Financial Advisors’s Portfolio BCAB Stock Details BCAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-2
Closed -$4K – 4648
2021
Q2 		$4K Buy
+2
New +$4.52K ﹤0.01% 3937

Other funds holding BCAB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

CAPTRUST Financial Advisors's BCAB Position: Q3 2021 in Review

CAPTRUST Financial Advisors sold out of BioAtla (BCAB) in Q3 2021, closing a stake of 2 shares — an estimated $4K sold.

CAPTRUST Financial Advisors first reported a position in BCAB in Q2 2021 and held it in 1 quarter. The position peaked at $4K in Q2 2021. 86 funds tracked by Wall St. Rank hold BCAB as of Q3 2021.

  • CAPTRUST Financial Advisors reported no remaining BioAtla position as of Q3 2021 after selling out during the quarter.
  • CAPTRUST Financial Advisors sold 2 BioAtla shares in Q3 2021, an estimated $4K.
  • CAPTRUST Financial Advisors first reported a position in BioAtla in Q2 2021 and held it in 1 quarter.
  • CAPTRUST Financial Advisors's BioAtla position peaked at $4K in Q2 2021.
  • 86 funds tracked by Wall St. Rank held BioAtla as of Q3 2021.

Based on CAPTRUST Financial Advisors's 13F filing for Q3 2021, filed 16 Nov 2021.